Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» CAR-T
CAR-T
CAR-T cells as 'bait' show promise in autoimmune disease
Fierce Biotech
Mon, 10/14/19 - 09:52 am
CAR-T
autoimmune disease
Italian gene therapy player draws new investor from China for its answer to CAR-T relapses
Endpoints
Tue, 09/10/19 - 11:37 pm
gene therapy
Genenta Science
clinical trials
glioblastoma
Multiple Myeloma
CAR-T
Trying to turn 'natural killers' against cancer, Nkarta raises $114 million
Bizjournals
Thu, 09/5/19 - 10:10 am
Nkarta Therapeutics
IPOs
cancer
natural killer cells
CAR-T
Achilles raises £100M for personalized T cell solid tumor trials
Fierce Biotech
Tue, 09/3/19 - 10:52 am
Achilles Therapeutics
solid tumors
CAR-T
Autolus drags on Arix after weak period for CAR-T player
Fierce Biotech
Wed, 08/28/19 - 10:54 am
Autolus Therapeutics
CAR-T
Arix Bioscience
Revealing the true value of new cancer drugs to payers
Pharmaforum
Sat, 08/10/19 - 02:00 pm
CAR-T
cancer
payers
Autolus delays multiple CAR-T clinical programs
Fierce Biotech
Fri, 08/9/19 - 10:55 am
Autolus
CAR-T
AUTO2
CMS to cover CAR-T therapy nationwide
Beckers Hospital Review
Thu, 08/8/19 - 10:53 am
Medicare
CMS
CAR-T
A personalized CAR-T to attack every solid tumor? Pact Pharma has a plan
Fierce Biotech
Mon, 07/22/19 - 08:05 pm
Pact Pharma
CAR-T
UCLA
solid tumors
personalized medicine
Precision BioSciences backs off-the-shelf cancer cell therapy effort with new manufacturing plant
Endpoints
Fri, 07/19/19 - 10:50 am
Precision Biosciences
cell therapy
CAR-T
drug manufacturing
Biotech building facility to make genome-edited, off-the-shelf CAR-T therapies
Fierce Pharma
Thu, 07/18/19 - 10:06 am
Precision Biosciences
CAR-T
drug manufacturing
Takeda Receives 1st Stem Cell-Derived CAR-T From Kyoto University Collaboration
BioSpace
Tue, 07/16/19 - 12:02 pm
Takeda
Kyoto University
CAR-T
stem cells
Gilead's Kite builds cell therapy manufacturing quickly even as Yescarta sales grow slowly
Fierce Pharma
Tue, 07/16/19 - 10:54 am
Gilead Sciences
Kte Pharma
Yescarta
CAR-T
cell therapy
Boosting CAR-T to treat solid tumors with a vaccine
Fierce Biotech
Thu, 07/11/19 - 05:22 pm
vaccines
CAR-T
cancer
cancer vaccines
Elicio
solid tumors
Are Natural Killer Cells the Next Big Thing in Immunotherapy?
Motley Fool
Mon, 07/8/19 - 09:51 am
immunotherapy
NK immunotherapies
CAR-T
Pressing the pause button on CAR-T cells with Bristol-Myers’ leukemia drug
Fierce Biotech
Fri, 07/5/19 - 01:35 pm
CAR-T
Bristol-Myers Squibb
cytokine release syndrome
OncoSec jumps into TNBC CAR T therapy via Dana-Farber deal
BioCentury
Sat, 06/29/19 - 02:33 pm
OncoSec
Dana-Farber
cell therapy
CAR-T
solid tumors
ASCO 2019 day two
Pharmaforum
Sun, 06/2/19 - 01:01 pm
Gilead Sciences
Kite Pharma
KTE-X19
CAR-T
ASCO 2019
Novartis
Merck
Keytruda
spartalizumab
Better than CAR-T? Already prepping for a US launch, MorphoSys posts stellar DLBCL data to field against Novartis, Gilead
Endpoints
Fri, 05/17/19 - 01:03 pm
CAR-T
MorphoSys
Novartis
Gilead Sciences
tafasitamab
DLBCL
Novartis takes another step forward in global Kymriah rollout as Japan OKs the drug at $305K
Endpoints
Wed, 05/15/19 - 10:31 am
Novartis
Kymriah
Japan
CAR-T
Pages
« first
‹ previous
…
8
9
10
11
12
13
14
15
16
…
next ›
last »